1. Home
  2. |Insights
  3. |Crowell & Moring Consumer Product Safety Seminar to Feature Senator Mark Pryor and Other Key Government Officials

Crowell & Moring Consumer Product Safety Seminar to Feature Senator Mark Pryor and Other Key Government Officials

Firm News | 2 min read | 10.05.11

Washington, D.C. – October 5, 2011: Crowell & Moring LLP is pleased to invite members of the media and industry to attend its one-day seminar, “Product Risk Management: A Product Lifecycle Approach to Identifying, Mitigating and Managing Legal Risks,” on October 19, 2011, from 8:45 a.m. – 4:45 p.m. at the firm’s offices in Washington, D.C. As regulatory compliance and enforcement risks for industry have increased, this one-day event for manufacturers and suppliers will feature insights from business executives, in-house counsel, and Washington agency officials.

The morning’s keynote address will be delivered by U.S. Senator Mark Pryor of Arkansas, who sponsored key amendments to the Consumer Product Safety Improvement Act of 2008 (CPSIA) that addressed longstanding complaints about some aspects of the law.

Speakers will include in-house counsel and executives from companies such as American Cleaning Institute, Avaya, Dana Holding Corporation, Dell Inc., FMC Corporation, Graco Children's Products, Inc., Limited Brands, Oneida, and Tesla Motors, as well as Crowell & Moring's wide range of regulatory, litigation, and international trade lawyers.

Government speakers will include:

  • Maria J. Doa, Director, Chemical Control Division, Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency
  • Stacey Ferguson, Senior Attorney, Division of Advertising Practices, Federal Trade Commission
  • Mark Josephs, Assistant Director, Consumer Protection Branch, U.S. Department of Justice
  • Melanie Sabo, Assistant Director, Anticompetitive Practices Division, Federal Trade Commission
  • O. Kevin Vincent, Chief Counsel, National Highway Traffic Safety Administration
  • Official from Office of Compliance and Field Operations, U.S. Consumer Product Safety Commission

Crowell & Moring partner Bridget E. Calhoun, who leads the firm’s Product Risk Management practice, said, “Manufacturers have faced increased regulatory enforcement and penalties, as well as more restrictive legislation. This conference is timely because it will stimulate discussion on agency priorities and industry best practices, as well as help businesses develop strategies to navigate and thrive in the current regulatory and litigation environment.”

A series of panels throughout the day will address product marketing; social media and advertising; distribution and regulatory compliance; automotive product safety and compliance; global product safety and compliance; antitrust issues; and investigations, enforcement, and litigation risk mitigation.

Crowell & Moring LLP is an international law firm with nearly 500 lawyers representing clients in litigation and arbitration, regulatory, and transactional matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation, as well as its ongoing commitment to pro bono service and diversity. The firm has offices in Washington, DC, New York, Los Angeles, San Francisco, Orange County, Anchorage, London, and Brussels.

Insights

Firm News | 1 min read | 03.11.25

Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo

March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn....